Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. Specifically provided is a composition for treating joint diseases that obtains higher efficacy than prior preparations by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is targeted at patients with human joint diseases who have a BMI of 25 kg/m2 or higher.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. Specifically provided is a composition for treating joint diseases that obtains higher efficacy than prior preparations by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is targeted at patients with human joint diseases who have a BMI of 25 kg/m2 or higher.

Abstract: The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.

Abstract: The ultrasonic sensor includes, on the same substrate, transmitter elements, receiver elements, a potential controller for receiver electrodes of the receiver elements, and a connection switching unit for the receiver electrodes and the potential controller. During the ultrasound transmission period of the transmitter elements, the connection switching unit connects the potential controller and one of the receiver electrodes, and connects the receiver electrodes. During the reception period of the receiver elements, the connection switching unit disconnects the potential controller and the one of the receiver electrodes, and disconnects the receiver electrodes.

Abstract: An ultrasonic device includes a plurality of piezoelectric elements, a driving electrode line connected to the piezoelectric elements, a first terminal, and a second terminal. The first terminal is connected to one end of the driving electrode line, and from the first terminal, a first driving signal for driving the piezoelectric elements, which is a voltage having an amplitude, is supplied to the piezoelectric elements. The second terminal is connected to another end of the driving electrode line, and from the second terminal, a second driving signal for driving the piezoelectric elements, which is a voltage having an amplitude, is supplied to the piezoelectric elements.

Abstract: A biological information measurement device adapted to measure biological information of a living body includes a board having a first surface and a second surface adapted to form two surfaces of the board with the first surface, a circuit element disposed on the first surface, and adapted to execute a predetermined process, and a sensor section disposed on the second surface, and adapted to detect the biological information, and the sensor section has a light emitter adapted to irradiate the living body with light, a light receiver adapted to receive reflected light reflected by the living body, and a sealing material having a light transmissive property, having contact with the living body, and adapted to seal the light emitter and the light receiver on the board.

Abstract: A photoelectric sensor includes a silicon substrate, a light emitter that emits first light, a light receiver that receives second light, a light emitter terminal that supplies the light emitter with electric power, and a light receiver terminal to which the light receiver outputs a signal, and the light emitter, the light receiver, the light emitter terminal, and the light receiver terminal are provided on the silicon substrate.

Abstract: Provided are an ultrasonic measurement apparatus, an ultrasonic imaging apparatus and an ultrasonic measurement method that achieve an increase in processing speed together with an increase in resolution and are user friendly. An image is generated by adding together, with a weight having a fixed value, reception signals obtained by ultrasonic echoes being received by an ultrasonic element array, and an area of interest is set within the area in which the generated image is to be displayed. When an area of interest is acquired, the reception signals received by the ultrasonic element array are added together with weights that depend on the reception signals, with respect to data forming the basis of the image to be displayed in the area of interest, and image generation is performed.

Abstract: An ultrasonic measurement apparatus includes an ultrasonic probe that emits an ultrasonic wave to the arm, detects a reflected wave from the arm, and outputs an ultrasonic signal, an image processing unit that forms an ultrasonic image on the basis of the ultrasonic signal, and a first display device and a second display device that displays the ultrasonic image, in which the ultrasonic image includes a blood vessel image indicating a blood vessel included in the arm, and a subtractive color needle image indicating a puncture needle inserted into the blood vessel, and in which predetermined colors corresponding to relative positions between the blood vessel and the puncture needle are displayed in the ultrasonic image.

Abstract: An ultrasonic sensor includes a plurality of ultrasonic wave elements each including a first electrode and a second electrode, and a control circuit configured to switch parallel connection and serial connection of the plurality of the ultrasonic wave elements.

Abstract: An ultrasonic device unit includes a substrate having a planar part and a recess part recessed from the planar part, an ultrasonic device which has an element array including a plurality of thin film ultrasonic transducer elements disposed in an array and is disposed in the recess part, a first flexible printed board, one end of which is superimposed on a portion of an array surface of the ultrasonic device and connected to the same, the other end of which is superimposed on a portion of the planar part and connected to the same, wherein the array surface of the ultrasonic device which the one end of the first flexible printed board is superimposed on is positioned within a plane including the planar part or a plane outside of the recess part.

Abstract: A control device for an ultrasonic apparatus includes: a reference value setting section that sets a reference value based on either the reflectance of an ultrasonic wave reflected from the interface with the air or the reflectance of an ultrasonic wave reflected from the interface with a measurement target; a reference period setting section that sets a reference period ended at the earlier time than the time of receiving an ultrasonic wave that is transmitted from an ultrasonic transducer element and is reflected from the measurement target; and a peeling detecting section that detects peeling of the ultrasonic transducer element by comparing a reception signal, which is output from the ultrasonic transducer element in the reference period, with the reference value.

Abstract: An ultrasonic device includes a plurality of piezoelectric elements, a driving electrode line connected to the piezoelectric elements, a first terminal, and a second terminal. The first terminal is connected to one end of the driving electrode line, and from the first terminal, a first driving signal for driving the piezoelectric elements, which is a voltage having an amplitude, is supplied to the piezoelectric elements. The second terminal is connected to another end of the driving electrode line, and from the second terminal, a second driving signal for driving the piezoelectric elements, which is a voltage having an amplitude, is supplied to the piezoelectric elements.

Abstract: An ultrasonic device includes an ultrasonic element group, a first to an Nth driving electrode lines, first and second terminals. The ultrasonic element group includes a plurality of ultrasonic elements forming “N” columns arranged along a second direction intersecting with a first direction with each of the “N” columns including a plurality of the ultrasonic elements arranged along the first direction, “N” being a natural number that is equal to or more than 2. The first to the Nth driving electrode lines are arranged along the first direction. An ith driving electrode line is connected to the ultrasonic elements constituting an ith column among the “N” columns, with “i” being a natural number equal to or less than “N”. The first terminal is connected to one end of the ith driving electrode line, and the second terminal is connected to the other end of the ith driving electrode line.

Abstract: An ultrasonic transducer device includes a substrate, an ultrasonic element array having a plurality of ultrasonic element rows each including a plurality of ultrasonic elements arranged along a first direction and electrically connected to each other, the plurality of ultrasonic element rows being arranged along a second direction intersecting with the first direction, and a plurality of common electrode wirings each configured to independently supply a common voltage to at least one of the ultrasonic element rows, the common electrode wirings extending along the first direction, one of the common electrode wirings being arranged between a pair of the ultrasonic element rows with respect to the second direction, the common electrode wirings being non-overlapped with the ultrasonic elements as viewed in a thickness direction of the substrate that is a normal direction of a surface of the substrate over which the ultrasonic element array is disposed.